Liver fibrosis accumulation is considered a turnover disease, with formation exceeding degradation Remodelling of extracellular matrix is crucial in progressive liver fibrosis. The role of basement membrane collagen type IV in advanced cirrhosis and acute decompensation may be an indicator of outcome.

Patients with decompensated cirrhosis from the prospective NEPTUN cohort (ClinicalTrials.gov Identifier: NCT03628807), who underwent transjugular intrahepatic portosystemic shunt procedure were included. Clinical and laboratory parameters, PRO-C4 and C4M levels were measured in blood samples from portal and hepatic veins just before transjugular intrahepatic portosystemic shunt placement.

Levels of C4M and PRO-C4 are significantly lower in patients with massive ascites and impaired renal sodium excretion. C4M and PRO-C4 show gender-specific profiles with significantly lower levels in females compared to males.

Therapeutic area
Gastroenterology, Cancer, Hepatic diseases, Respiratory diseases, Rheumatology

Biomarker panels
Lung Epithelial Damage, Pericellular Fibrosis Remodelling, Hepatic Fibrosis Outcome, Tissue Fibrosis, Angiogenesis / Basement Membrane, Tissue Fibrosis

Function
Basement membrane synthesis, ECM formation

Alternative names
P4NP7S, PROC4

Certification
-

Platform
ELISA and/or on high-precision platform

Sample type
Serum

Sample volume
50 µl

Healthy reference range
Reach out to learn more

Species (Tested in)
N/A

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.